T
Tobias R. Kollmann
Researcher at Telethon Institute for Child Health Research
Publications - 198
Citations - 10070
Tobias R. Kollmann is an academic researcher from Telethon Institute for Child Health Research. The author has contributed to research in topics: Vaccination & Immune system. The author has an hindex of 48, co-authored 181 publications receiving 7929 citations. Previous affiliations of Tobias R. Kollmann include Yeshiva University & University of Washington.
Papers
More filters
Journal ArticleDOI
Drug-resistant tuberculosis: pediatric guidelines
Mona Al-Dabbagh,Keswadee Lapphra,Rumi McGloin,Kelsey Inrig,H. Simon Schaaf,Ben J. Marais,Laura Sauve,Ian Kitai,Tobias R. Kollmann +8 more
TL;DR: The literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting is reviewed.
Journal ArticleDOI
Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
Tobias R. Kollmann,Massimo Pettoello-Mantovani,Nikos F. Katopodis,Moshe Hachamovitch,Arye Rubinstein,Ana Kim,Harris Goldstein +6 more
TL;DR: The demonstration of the vivo inhibitory effect of IL-10 on acute HIV infection suggests that further studies may be warranted to evaluate whether there is a role for IL- 10 therapy in preventing HIV infection in individuals soon after exposure to HIV such as for children born to HIV-infected mothers.
Journal ArticleDOI
A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
Amy L. Slogrove,Monika Esser,Mark F. Cotton,David P. Speert,Tobias R. Kollmann,Joel Singer,Julie A. Bettinger +6 more
TL;DR: The difference between HIV-infected and HIV-uninfected mothers and their newborns from South African community midwife unit in the probability of infectious cause hospitalization or death in the first 6 months of life was not significant, however, among breastfed infants, severe infectious morbidity occurred more often in HEU than HU infants.
Journal ArticleDOI
The Canadian healthy infant longitudinal development birth cohort study: biological samples and biobanking.
Theo J. Moraes,Diana L. Lefebvre,Rishma Chooniedass,A.B. Becker,Jeffrey R. Brook,Jeffrey R. Brook,Judah A. Denburg,Kent T. HayGlass,Richard G. Hegele,Tobias R. Kollmann,Joseph Macri,P. J. Mandhane,James A. Scott,Padmaja Subbarao,Timothy K. Takaro,Stuart E. Turvey,J D Duncan,Malcolm R. Sears,A. D. Befus,Child Study Investigators +19 more
TL;DR: The Canadian Healthy Infant Longitudinal Development (CHILD) study was designed to explore the complex interactions between genetic and environmental factors that give rise to allergy and asthma in childhood.
Journal ArticleDOI
Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells
Hong Yang,Hong Yang,Lisa K. Kozicky,Aabida Saferali,Shan-Yu Fung,Nicole Afacan,Bing Cai,Reza Falsafi,Erin E. Gill,Mingyao Liu,Tobias R. Kollmann,Robert E. W. Hancock,Laura M. Sly,Stuart E. Turvey +13 more
TL;DR: A nano-based TLR inhibitor (peptide-gold nanoparticle hybrids) is developed that inhibits a broad spectrum of TLR responses and identifies specific peptide decorated nanoparticles that may represent a novel class of anti-inflammatory therapeutics for human inflammatory diseases.